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In 1961, Rowe and Capps(1) described a murine herpesvirus, now known as mouse
thymic virus (MTLV; ICTV designation murid herpesvirus 3), which caused severe
thymic necrosis and acute immunosuppression in newborn mice (1-4). Although
the thymus and the affected peripheral lymphoid tissues regenerate within 1-2 mo
after infection, infected animals continue to shed virus for life (1, 3). MTLV is a
good candidate for a T lymphocytolytic virus. Virus and viral antigen are present
in infected thymuses (3), and T lymphocytes may be required for infection (5). How-
ever, little is known about specific T lymphocyte target cells in vivo for lymphotropic
herpesviruses.
Mouse thymocytes can be phenotyped using mAbs to the principal T lymphocyte
surface markers CD4 (L3T4) and CD8 (Lyt-2) (6). These surface markers define
four major thymocyte subpopulations (CD4'8', CD4'8-, CD4- 8', and CD4- 8- ).
In the mouse, most thymocytes are immature cortical double-positive (CD4' 8' )
cells, representing 80-90% of the total, while mature functional thymocytes are
CD4' 8- (approximately equivalent to human T4 helper/inducer T lymphocytes)
or CD4-8' (6) . We here report that the CD4' cell is the major lytic target in the
thymus for MTLV infection.





Mice, obtained from The Rockefeller University Laboratory Animal Research
Center barrier breeding colony (BALB/c) or from Taconic Farms, Germantown, NY (Ta-
conic Swiss), were free of murine pathogens including MTLV (4). Mice had food and water
ad libitum, and were treated in accordance with National Institutes of Health guidelines.
Virus.
￿
For virus pools (3), litters of newborn (424 h old) BALB/c or Taconic Swiss mice
were inoculated intraperitoneally (30-gauge needle) with 0.05 ml MTLV per neonatal mouse.
Thymuses were harvested 7 d later and 10%v (wt/vol) homogenates were prepared in culture
medium (DME or Iscove's; Gibco Laboratories, Grand Island, NY) supplemented with 10%
FCS (HyClone Laboratories, Logan UT). The virus pool was stored at -70'C after the
addition of DMSO (Sigma Chemical Co., St. Louis, MO) to a final concentration of 10%.
Virus titer was generally 3 .5-4.2 logio ID5o per ml as calculated by the Spearman-Karber
method (7). For virus titration, serial 10-fold dilutions of virus were inoculated into litters
of newborn mice (0.05 ml per mouse). The pups were examined at 9 d for macroscopic thymic
necrosis. Control homogenates of uninfected thymuses did not induce thymic necrosis.
Thymocyte Preparation andAnalysis.
￿
Newborn mice were either left uninfected (control) or
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infected with -50 ID50 of MTLV per mouse. Thymocytes were harvested by standard
methods (8). Briefly, thymuses from each group of suckling mice were collected, placed into
sterile 60-mm tissue culture dishes (Corning, Corning, NY) containing 1 ml Iscove's medium
with 10% FCS, and disaggegated with forceps. The suspensions were transferred to sterile
15-cc conical polypropylene centrifuge tubes (Corning), diluted to 5 ml with medium, al-
lowed to settle for 5 min, and the supernatant fluid was then transferred to new tubes. After
viable counts in isotonic 0.04% trypan blue (Gibco Laboratories), 106 cells from each sample
were transferred to 1.5 ml polypropylene microcentrifuge tubes (Fisher Scientific Co.,
Springfield, NJ), gently pelleted in a microcentrifuge (Fisher Model 59A, 5 min at setting
2) and washed once with HBSS (Gibco Laboratories). For staining, fluorescent labeled rat
mAbs to mouse CD4 (anti-L3T4 phycoerythrir conjugate, Becton Dickinson & Co., Moun-
tain View, CA) and CD8 (anti-Lyt-2 fluorescein conjugate, Becton Dickinson & Co.) were
mixed together at a 1 :40 dilution in HBSS. Each cell pellet (106 cells) was gently resuspended
in 100 pl of the antibody preparation and incubated for 45 min at 4'C. After incubation,
the cellswere diluted to 1 ml with Iscove's medium containing logo FCS, gently pelleted, washed
once with additional medium, and resuspended in 0.5 ml ofthe same medium. Control thymo-
cytes afterprocessing were >90% viable by trypan blue count. Cells were analyzed by flow
cytometry within 2 h, except for experiments in Table II, where stained cells were fixed at
4'C in freshly prepared 2% paraformaldehyde (9) and kept at 4'C in the dark for analysis
within 1 wk. Comparisons of fresh vs. paraformaldehyde-fixed samples indicated only min-
imal changes in the cells. Two-color flow cytometric analysis, using a minimum of 10,000
cells for each determination, was performed with a B-D FAGS 440 cell sorter (Becton Dick-
inson & Co., Mountain View, CA) equipped with Spectra-Physics laser. Except for Fig. 1,
dead cells were removed by gating, with gates set using control thymocytes (>90% viable).
Results
Thymic necrosis resulted, as expected (3, 4), in virtually all inoculated suckling
mice. Macroscopic necrosis peaked at N8-11 d. Infected thymuses were generally
<10% of normal size and weight. Some infected thymuses were only moderately
necrotic; these were generally -25% of normal size.
Infection caused a marked decrease in both subpopulations ofCD4 bearing thymo-
cytes (both CD4+ 8' and CD4+ 8") (Fig. 1, B-C), as compared with controls (Fig.
1 A). At the peak of necrosis, CD4' 8' cells were reduced considerably below con-
trol levels, by a degree that appeared to depend on severity of necrosis (Fig. 1, B
and C). CD4'8- cells were even more strikingly reduced, to 1% or less of total
thymocytes in all cases. The major surviving lymphocytes were CD4- 8' and
CD4- 8- cells. These effects were not strain specific. Similar results were obtained
with Taconic Swiss mice.
Calculations of yields of each cell population per thymus revealed that while
CD4 - 8' and CD4- 8- populations appeared to increase relative to the other popu-
lations, their absolute numbers were not increased (Table I). In contrast, CD4' 8 -
cells were reduced to 2% or less of control.
To determine whether there were any differences in the two CD4' populations
(CD4' 8 - and CD4' 8' ), numbers of CD4' cells in the thymus were monitored
during the first week of infection, before gross thymic necrosis was visible. As shown
in Table II, both populations remained at control levels for the first 3 d after infec-
tion. CD4' 8- cells began to decline on the fourth day after infection, while
CD4' 8' cells appeared to remain at normal levels through day 5, then declined.
CD4' 8' cells on day 5 were present at 980 /c of control levels ; total cell yields and
thymic appearance were normal. Day 6 thymuses were macroscopically normal, but





Two-color immunofluorescent flow cytometric analysis of thymocyte subpopulations
in MTLVinfected mice . Log fluorescence intensity of staining with anti-CD8-fluorescein (x axis)
and anti-CD4-phycoerythrin (y axis) of thymocytes from control BALB/c suckling mice (A) or
from MTLV infected mice (8 d after infection) showing moderate thymic necrosis (B) or severe
thymic necrosis (C) . Each cell is represented by one dot . Thymdcyte subpopulations (with data
gated for live lymphocytes) calculated as percent of total thymocytes remaining in each population :
Discussion
The data presented here indicate thatMTLV infection is preferentially cytolytic
for CD4' cells . CD4'8- cells in the thymus were virtually eliminated irrespective
of the apparent severity of the infection . CD4' 8 - cells, unlike CD4' 8' thymocytes,
are immunocompetent cells (6) . The selective loss ofCD4' 8- cells (as compared
with CD4- 8' cells) correlates well with the immunosuppression that was reported
to occurduring acute infection with thymic virus (2), which involved loss of helper
cell activity, but not of suppressor activity.
TABLE I
Absolute Numbers of Each Thymocyte Subpopulation in MTLV-infected Mice
Thymuses from control and infected mice (moderately or severely necrotic) were harvested
8 d after infection and thymocytes were prepared and analyzed as for Fig . 1 . Percentages of
cells in each population, as determined by two-color flow cytometry (gated data), were multi-
plied by the viable count (in 0.04% trypan blue) for each sample to obtain absolute yields of











(A) Control 3.8 89.0 2.9 2 .6
(B) Infected (mod-
erately necrotic) 0 .7 58 .1 23 .1 15.2
(C) Infected (se-







CD4 - 8' CD4 - 8 -
Control 3 .1 x 108 1 .2 x 10' 2.8 x 108 9.4 x 106 8.4 x 10 6
Infected (mod-
erate necrosis) 2.4 x 10' 1 .7 x 105 1 .4 x 107 5 .7 x 10 6 3 .7 x 10 6
Infected (severe






Changes in Thymocyte Subpopulalions during Course of Infection
Thymocytes from age-matched control and infected mice (Taconic Swiss strain)
were harvested and phenotyped on the days indicated .
In contrast to the CD4' populations, CD4- 8' and CD4 - 8 - cells appeared
largely to be spared. Gating should have excluded dead cells from being miscounted
as CD4- 8 - . Mosier et al . (10) found that >900 /o of thymocytes from both MTLV
infected and normal thymuses also stained identically for Ly-1, Ly-2 (CD8), and Ly-3.
The loss of CD4 bearing cells also appears specific to this virus, and not a general-
ized effect of damage to the thymus . Several othertreatments reported to cause thymic
atrophy, including malnutrition (11) and mouse cytomegalovirus infection concur-
rent with induced graft-vs.-host reaction (12), showed virtually normal CD4/CD8
subpopulation distributions even when totalthymocyte numbers were greatly reduced.
Because MTLV is present in infected thymuses (3), cytolytic infection appears
the most likely explanation for thymocyte loss after MTLV, but alternative mecha-
nisms are possible. MTLV could inappropriately trigger normal thymic mechanisms
for clonal elimination of self-reactive T lymphocytes (13), or primary infection of
nonlymphocyte cells by the virus could result in loss of thymocytes as an indirect
effect. Glucocorticoid induction during infection is also a possible mechanism (14),
but it appears unlikely to be responsible for the loss of the more mature CD4' 8 -
cells, which are generally considered cortisone resistant (8).
It is intriguing to speculate from the results that the CD4 molecule may be the
virus receptor, as it is for HIV 1 (15, 16), but the evidence is insufficient to support
this hypothesis. Our preliminary results from cell sorting experiments suggest in-
stead that at least some CD4 - cells may become infected with the virus but sur-
vive. These surviving cells could remain infected and serve as a reservoir of chronic
infection with prolonged virus shedding. The cell type in which the virus persists
is unknown, but other evidence implicates a T lymphocyte population (5).
There are likely to be other T lymphocytolytic viruses in nature with a similar
predilection for CD4 bearing cells. One possible parallel is the recently described
human herpesvirus 6 (HHV6), also known as HBLV (17). Originally isolated from
B lymphocytes, HHV6 was recently demonstrated able to cytolytically infect a human
T lymphoblastoid line in vitro (18), although cytolytic infection of T lymphocytes
by HHV6 has yet to be demonstrated definitively in vivo. I have found growth of
MTLV in several T lymphoblastoid lines tested, including three CD4' human lines
(Morse, S. S., manuscript submitted for publication). HHV6 has other similarities










2 9.6 97 .8 76.8 96.1
3 8.2 99.2 79 .4 102.0
4 6.7 81 .3 83 .7 102.0
5 3.0 72 .5 80.1 97.9





(19) . MTLV andHHV6 might be the first identified members of a family of lym-
photropic, T cytolytic herpesviruses .
Summary
Mouse thymic virus (MTLV; ICTV designation murid herpesvirus 3) infects de-
veloping T lymphocytes of neonatal mice, causing thymic necrosis and acute im-
munosuppression . Infected animals shed virus indefinitely. In the present report,
two-color flow cytometric analysis of T lymphocyte subpopulations defined by the
markers CD4 (L3T4) and CD8 (Lyt-2) was used to determine whetherMTLV was
lytic for a specific thymocyte population . At peak necrosis (8-11 d after infection),
numbers of CD4'8' cells in the thymus were reduced by 80% or more as com-
pared with controls, and CD4'8- cells were reduced by >98% . The major survivors
were CD4- 8' and CD4- 8- lymphocytes . These data indicate that the CD4 bearing
lymphocyte is a primary target for cytolysis during MTLV infection . Possible parallels
between MTLV and a newly described lymphotropic human herpesvirus, human
herpesvirus 6 (HHV6/HBLV), are also suggested .
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